Background Image
Table of Contents Table of Contents
Previous Page  13 / 68 Next Page
Information
Show Menu
Previous Page 13 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 1, January/February 2015

AFRICA

11

aorta in children with asthma and in a control group. Our

hypothesis was that since asthma is a chronic inflammatory

disease, it could lead to the early development of atherosclerosis

in childhood-onset asthma.

To detect the effect of inflammation, we included patients

with a diagnosis of asthma of at least three years’ duration.

As a marker of atherosclerosis, we evaluated abdominal aortic

stiffness parameters with transthoracic echocardiography.

Stiffness and distensibility assessments of the abdominal aorta

play an important role in evaluation of the elasticity of the

arterial system. If there is atherosclerosis, aortic stiffness, Ep and

Ep* will increase, whereas DIS and S will decrease. S and DIS

represent the elasticity of the abdominal aortic wall.

In the literature, aortic distensibility has been shown to

be useful in adults as a non-invasive method to detect early

atherosclerosis. The increased stiffness causes an increase in

pulse pressure and a decrease in diastolic blood pressure,

thereby causing increased left ventricular afterload and increased

fatigue in arterial wall tissues. Previous studies have shown that

measurement of aortic stiffness helps in the early detection of

atherosclerosis, and the abdominal aorta becomes stiffer with

age, hypertension, atherosclerosis, tobacco-smoking, obesity, and

in

β

-thalassaemia patients and patients with Marfan syndrome

and Kawasaki disease.

11,13,14

Lacombe

et al.

demonstrated that in subjects older than

20 years of age, S, Ep and Ep* were related to age due to

atherosclerosis.

10

We calculated S, Ep, Ep* and distensibility

using the formula proposed by Lacombe and Lage

et al.

10,15

Okubo found that aortic distensibility varies with age; it was low

in infants, increased gradually to a peak from 10–15 years, and

then decreased with age.

11

Atherosclerosis and asthma are both chronic inflammatory

diseases. Inflammation leads to impairment of endothelial

function. When the inflammation is chronic, this causes

acceleration of atherosclerosis.

18

In the literature, some studies

have stated that asthma itself could be a risk factor for heart

disase and stroke.

19,20

Related to increased oxidative stress, asthma is a chronic

inflammatory disease.

21

The association between chronic

inflammation and oxidative stress is well documented. In asthma

patients with inflammatory conditions, elevated levels of reactive

oxygen species, such as hydroxyl radicals, superoxides and

peroxides have been reported.

22

Chronic inflammation has

also been increasingly associated with endothelial dysfunction,

atherosclerosis

and arterial stiffness, and these in turn with

adverse cardiovascular events and common inflammatory

pathways.

23,24

Some studies have evaluated the relationship between adult-

onset asthma and atherosclerosis but the results are contradictory.

Onufrak

et al

. showed that in adult-onset asthma patients, the

risk of atherosclerosis was increased.

25

However, in another

study by Otsuki

et al

., carotid atherosclerosis was reduced in

asthmatic adult patients treated with inhaled corticosteroids

compared with matched controls, and they found that inhaled

corticosteroids had protective effects against atherosclerosis.

26

Weiler

et al.

found significant correlations between

measurements of periferal arterial stiffness and FEV1 in

adult asthmatics, and suggested the presence of a common

systemic, most likely inflammatory pathway involving both

the cardiovascular and respiratory systems.

27

In another study

of adult asthmatics, Sun

et al.

found that that patients with

severe asthma had increased brachial–ankle pulse-wave velocity

(baPWV) compared with those with stable asthma and control

subjects. Furthermore, baPWV was elevated in patients with

stable asthma compared with the control subjects.

28

However, there are only a few studies evaluating the

relationship between childhood-onset asthma and atherosclerosis.

In the study of Cakmak

et al

.,

29

carotid intima–media thickness

(CIMT) in asthmatic children was found to be higher compared

to the control group and there was a positive correlation between

CIMT and total oxidant status. They studied only children

with mild asthma who were not using prophylactic inhaled

corticosteroids.

In all these studies, CIMT was evaluated as a marker of

atherosclerosis. However, in our study, we evaluated abdominal

aortic stiffness as a sign of atherosclerosis in childhood asthma.

In our investigation, the study population consisted of

children with stable asthma. We did not evaluate aortic stiffness

parameters in children with severe asthma. Further studies

including larger population size and children with severe asthma

may reveal different results regarding abdominal aortic stiffness.

In our study, we used only hs-CRP as an inflammatory

marker. An inflammatory marker showing oxidant status could

not be studied.

Table 4. Aortic stiffness parameters in patients with

intermediate severity asthma and the control group

Intermediate-

severity asthma

patients (

n

=

18)

Control group

(

n

=

57)

p

-value

Peak aortic velocity, cm/s 125.6

±

16.7

123.5

±

17.9

>

0.05

Ds, mm

11.4

±

2.0

11.1

±

1.9

>

0.05

Dd, mm

8.2

±

1.5

8.2

±

1.8

>

0.05

DIS, 10

-6

cm

2

/dyne

1.31

±

0.51

1.41

±

0.66

>

0.05

S

0.39

±

0.10

0.37

±

0.14

>

0.05

Ep, N/m

2

105.9

±

42.4

116.5

±

55.9

>

0.05

Ep*

1.71

±

0.74

1.83

±

0.90

>

0.05

Data are presented as mean

±

standard deviation.

Dd: abdominal aorta diastolic diameter, DIS: aortic distensibility, Ds:

abdominal aorta systolic diameter, Ep: pressure strain elastic modulus,

Ep*: pressure strain normalised by diastolic pressure, S: aortic strain.

Table 5. Aortic stiffness parameters in asthma patients

with atopy and the control group

Asthma patients

with atopy

(

n

=

37)

Control group

(

n

=

57)

p

-value

Peak aortic velocity, cm/s

128.0

±

16.5 123.5

±

17.9

>

0.05

Ds, mm

11.5

±

1.9

11.1

±

1.9

>

0.05

Dd, mm

8.3

±

1.3

8.2

±

1.8

>

0.05

DIS, 10

-6

cm

2

/dyne

1.31

±

0.51

1.41

±

0.66

>

0.05

S

0.38

±

0.12

0.37

±

0.14

>

0.05

Ep, N/m

2

105.4

±

35.6 116.5

±

55.9

>

0.05

Ep*

1.69

±

0.66

1.83

±

0.90

>

0.05

Data are presented as mean

±

standard deviation.

Dd: abdominal aorta diastolic diameter, DIS: aortic distensibility, Ds:

abdominal aorta systolic diameter, Ep: pressure strain elastic modulus,

Ep*: pressure strain normalised by diastolic pressure, S: aortic strain.